Lv4
500 积分 2025-04-29 加入
861-P: Targeting Activin Type II Receptors—Develop Monoclonal Antibodies LAE102, LAE103, and LAE123 as Candidate Therapeutics for Muscle Growth and Fat Reduction
2个月前
已关闭
Antagonists of activin signaling: mechanisms and potential biological applications
2个月前
已完结
Models and methods for studying insurmountable antagonism
5个月前
已完结
Recent Progress and Prospects of Small Molecules for NLRP3 Inflammasome Inhibition
6个月前
已完结
皖公网安备34019202002308
